• 1
    Olin JJ (2001) Cognitive function after systemic therapy for breast cancer. Oncology, 15, 613618.
  • 2
    Anderson-Hanley C, Sherman ML, Riggs R, Agocha B, Compas B (2003) Neuropsychological effect of treatments for adults with cancer: A meta-analysis and review of the literature. Journal of the International Neuropsychological Society, 9, 967982.
  • 3
    Phillips KA, Bernhard J (2003) Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions. Journal of the National Cancer Institute, 95, 190197.
  • 4
    Tannock IF, Tim AA, Ganz PA, van Dam FS (2004) Cognitive impairment associated with chemotherapy for cancer: report of a workshop. Journal of Clinical Oncology, 22, 22332239.
  • 5
    Wieneke MH, Dienst ER (1995) Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psychooncology, 4, 6166.
  • 6
    Van Dam FS, Schagen SB, Muller MJ, Boogerd W, Wall E, Fortuyn M, Rodenhuis S (1998) Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. Journal of the National Cancer Institute, 90, 210218.
  • 7
    Schagen S, van Dam F, Muller M, Boogerd W, Lindeboom J, Bruning P (1999) Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer, 85, 640650.
  • 8
    Schagen SB, Muller MJ, Boogerd W, Rosenbrand RM, Rhijn D, Rodenhuis S, van Dam FS (2002) Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Annals of Oncology, 13, 13871397.
  • 9
    Brezden C, Phillips K, Abdolell M, Bunston T, Tannock I (2000) Cognitive function in breast cancer patients receiving adjuvant chemotherapy. Journal of Clinical Oncology, 18, 26952701.
  • 10
    Ahles TA, Saykin AJ, Furstenberg CT et al. (2002) Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology, 20, 485493.
  • 11
    O'Shaughnessy JA (2002) Effects of epoetin alfa on cognitive function, mood, asthenia, and quality of life in women with breast cancer undergoing adjuvant chemotherapy. Clinical Breast Cancer, 3(Suppl. 3), S116S120.
  • 12
    Tchen N, Juffs HG, Downie FP et al. (2003) Cognitive changes, fatigue and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer: a prospective matched cohort study. Journal of Clinical Oncology, 21, 41754183.
  • 13
    Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA (2004) The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer, 100, 22922299.
  • 14
    Meyers C (2000) Neurocognitive dysfunction in cancer patients. Oncology, 14, 7581.
  • 15
    Silberfarb PM, Philibert D, Levine PM (1980) Psychosocial aspects of neoplastic disease: II. Affective and cognitive effects of chemotherapy in cancer patients. American Journal of Psychiatry, 137, 597601.
  • 16
    Schagen SB, Hamburger HL, Muller MJ et al. (2001) Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function. Journal of Neurooncology, 51, 159165.
  • 17
    Kingma A, van Dommelen RI, Mooyaart EL, Wilmink JT, Deelman BG, Kamps WA (2001) Slight cognitive impairment and magnetic resonance imaging abnormalities but normal school levels in children treated for acute lymphoblastic leukemia with chemotherapy only. Journal of Pediatrics, 139, 413420.
  • 18
    Kibiger G, Kirsh KL, Wall JR, Passik SD (2003) My mind is as clear as it used to be: a pilot study illustrating the difficulties of employing a single-item subjective screen to detect cognitive impairment in outpatients with cancer. Journal of Pain and Symptom Management, 26, 705715.
  • 19
    Appleton RE, Farrell K, Zaide J, Rogers P (1990) Decline in head growth and cognitive impairment in survivors of acute lymphoblastic leukemia. Archives of Disease in Childhood, 65, 530534.
  • 20
    Van Oosterhout AG, Ganzevles PG, Wilmink JT, De Geus BW, Van Vonderen RG, Twijnstra A (1996) Sequelae in long-term survivors of small cell lung cancer. International Journal of Radiation Oncology and Biological Physics, 34, 10371044.
  • 21
    Ahles TA (2004) Do systemic cancer treatments affect cognitive function? Lancet Oncology, 5, 270271.
  • 22
    Riva D, Giorgi C, Nichelli F et al. (2002) Intrathecal methotrexate affects cognitive function in children with medulloblastoma. Neurology, 59, 4853.
  • 23
    Brown RT, Madan-Swain A, Walco GA et al. (1998) Cognitive and academic late effects among children previously treated for acute lymphocytic leukemia receiving chemotherapy as CNS prophylaxis. Journal of Pediatric Psychiatry, 23, 333340.
  • 24
    Shilling V, Jenkins V, Fallowfield L, Howell T (2003) The effects of hormone therapy on cognition in breast cancer. Journal of Steroid Biochemistry and Molecular Biology, 86, 405412.
  • 25
    Cimprich B, Ronis DL (2001) Attention and symptom distress in women with and without breast cancer. Nursing Research, 50, 8694.
  • 26
    Wefel S, Lenzi R, Theriault R, Buzdar A, Cruickshank S, Meyers C (2004) ‘Chemobrain’ in breast carcinoma? A prologue. Cancer, 101, 466475.
  • 27
    Hannay HJ, Levin HS (1985) Selective reminding test: an examination of the equivalence of four forms. Journal of Clinical and Experimental Neuropsychology, 7, 251263.
  • 28
    Almeida OP, Flicker L (2001) The mind of a failing heart: a systematic review of the association between congestive heart failure and cognitive functioning. Internal Medicine Journal, 31, 290295.
  • 29
    Allena KV, Frier BM, Strachan MWJ (2004) The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. European Journal of Pharmacology, 490, 169175.
  • 30
    Liesker JJ, Postma DS, Beukema RJ et al. (2004) Cognitive performance in patients with COPD. Respiratory Medicine, 98, 351356.
  • 31
    Antonelli Incalzi R, Marra C, Giordano A et al. (2003) Cognitive impairment in chronic obstructive pulmonary disease. A neuropsychological and SPECT study. Journal of Neurology, 250, 325332.
  • 32
    Wilson RS, Mendes de Leon CF, Bennett DA, Bienias JL, Evans DA (2004) Depressive symptoms and cognitive decline in a community population of older persons. Journal of Neurology and Neurosurgical Psychiatry, 75, 1212612129.
  • 33
    Holland J (2001) New treatment modalities in radiation therapy. Journal of Intravenous Nursing, 24, 95101.
  • 34
    Noad R, Narayanan KR, Howlett T, Lincoln NB, Page RC (2004) Evaluation of effects of radiotherapy for pituitary tumors on cognitive function and quality of life. Clinical Oncology Royal College Radiologists, 16, 233237.
  • 35
    Keime-Guibert F, Napolitano M, Delattre J (1998) Neurological complications of radiotherapy and chemotherapy. Journal of Neurology, 245, 695708.
  • 36
    Bonadonna G, Brusamolino E, Valagussa P (1976) Combination chemotherapy as an adjuvant treatment in operable breast cancer. New England Journal of Medicine, 294, 405410.
  • 37
    Bonadonna G, Valagussa P, Moliterni A, Zambetti M, Brambilla C (1995) Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years follow-up. New England Journal of Medicine, 332, 901906.
  • 38
    Harris J, Morrow M, Norton L. (1997) Cancer of the breast. In: DeVitaVT, HellmanS, RosenbergSA, eds. Cancer: principles & practice of oncology, vol. 2, 5th edn. Philadelphia: Lippincott-Raven Publishers, 15411616.
  • 39
    Kemper E, Boogerd W, Thuis I, Beijnen JH, van Tellingen O (2004) Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours? Cancer Treatment Reviews, 30, 415423.
  • 40
    Neuwelt EA, Barnett P, Barranger J, McCormick C, Pagel M, Frenkel E (1983) Inability of dimethyl sulfoxide and 5-fluorouracil to open the blood-brain barrier. Neurosurgery, 12, 2934.
  • 41
    MacDonell LA, Potter PE, Leslie RA (1978) Localized changes in blood-brain barrier permeability following the administration of antineoplastic drugs. Cancer Research, 38, 29302934.
  • 42
    Fenner MH, Possinger K (2002) Chemotherapy for breast cancer brain metastases. Onkologie, 25, 474479.
  • 43
    Neuwelt EA, Barnett PA, Frenkel EP (1984) Chemotherapeutic agent permeability to normal brain and delivery to avian sarcoma virus-induced brain tumors in the rodent: observations on problems of drug delivery. Neurosurgery, 14, 154160.
  • 44
    Fliessbach K, Urbach H, Helmstaedter C et al. (2003) Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma. Archives of Neurology, 60, 563568.
  • 45
    Rock E, DeMichele A (2003) Nutritional approaches to late toxicities of adjuvant chemotherapy in breast cancer survivors. Journal of Nutrition, 133, 3785S3793S.
  • 46
    Birge SJ (2003) The use of estrogen in older women. Clinical Geriatric Medicine, 19, 617627.
  • 47
    Cunningham RS (2003) Anemia in the oncology patient: cognitive function and cancer. Cancer Nursing, 26, 39S41S.
  • 48
    Maier SF, Watkins LR (2003) Immune-to-central nervous system communication and its role in modulating pain and cognition: implications for cancer and cancer treatment. Brain, Behavior and Immunity, 17, S125S131.
  • 49
    Pusztai L, Mendoza TR, Reuben JM et al. (2004) Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine, 25, 94102.
  • 50
    Wilson CJ, Finch CE, Cohen HJ (2002) Cytokines and cognition – the case for a head-to-toe inflammatory paradigm. Journal of the Geriatric Society, 50, 20412056.
  • 51
    Sallah S, Wan JY, Nguyen NP (2002) Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thrombosis Haemostasis, 87, 575579.
  • 52
    Caine GJ, Stonelake PS, Rea D, Lip GY (2003) Coagulopathic complications in breast cancer. Cancer, 98, 15781586.
  • 53
    Love S. (2006) Chemobrain/cognitive dysfunction. The website for women. (accessed on 23 March 2006).
  • 54
    Foreman J. (2003) ‘‘Chemo Brain“ leaves patients at a loss. Health sense columns, .
  • 55
    Madhyastha S, Somayaji SN, Rao MS, Nalini K, Bairy KL (2002) Hippocampal brain amines in methotrexate-induced learning and memory deficit. Canadian Journal of Physiology and Pharmacology, 80, 10761084.